Search results for TNF alpha

Anti-Human TNFa/TNF-alpha Antibody (SAA0415), FITC (HF879117), abinScience, HF879117

Anti-Human TNFa/TNF-alpha Antibody (SAA0415), APC (HF879137), abinScience, HF879137

Nerelimomab Biosimilar – Anti-TNFSF2, TNF-alpha, TNFA mAb – Research Grade, ProteoGenix, PX-TA1219

Description of Nerelimomab Biosimilar - Anti-TNFSF2, TNF-alpha, TNFA mAb - Research Grade Introduction Nerelimomab Biosimilar, also known as Anti-TNFSF2 or TNF-alpha monoclonal antibody (mAb), is a research grade therapeutic agent that targets the cytokine TNF-alpha. This protein is a key mediator of inflammation and is involved in a variety of diseases such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Nerelimomab Biosimilar is a promising treatment option for these conditions and has the potential to improve patient outcomes. Structure of Nerelimomab Biosimilar Nerelimomab Biosimilar is a monoclonal antibody, meaning it is a laboratory-produced protein that mimics the body’s natural antibodies. The antibody is composed of two heavy chains and two light chains, each containing a variable region and a constant region. The variable region is responsible for binding to the target protein, while the constant region is involved in immune system activation. Activity of Nerelimomab Biosimilar Nerelimomab Biosimilar binds specifically to TNF-alpha, preventing it from binding to its receptors and exerting its pro-inflammatory effects. This leads to a decrease in inflammation and symptoms associated with diseases where TNF-alpha is overproduced. Additionally, Nerelimomab Biosimilar can also promote the clearance of TNF-alpha by activating the immune system to recognize and remove the bound protein. Application of Nerelimomab Biosimilar Nerelimomab Biosimilar has shown promising results in preclinical studies for the treatment of various inflammatory diseases. In a mouse model of rheumatoid arthritis, Nerelimomab Biosimilar significantly reduced joint inflammation and destruction. It has also been shown to be effective in treating inflammatory bowel disease, with a reduction in symptoms and improvement in intestinal tissue damage. In addition to its potential as a therapeutic agent, Nerelimomab Biosimilar has also been used in research to study the role of TNF-alpha in various diseases. By blocking TNF-alpha activity, researchers can better understand the mechanisms of inflammation and potentially identify new therapeutic targets. Future Directions Nerelimomab Biosimilar is currently in the research and development stage, with clinical trials underway to evaluate its safety and efficacy in human patients. If successful, it has the potential to become a valuable treatment option for inflammatory diseases with limited treatment options. Furthermore, ongoing research on the role of TNF-alpha in other diseases may lead to the discovery of new applications for Nerelimomab Biosimilar. Conclusion Nerelimomab Biosimilar is a promising research grade therapeutic agent that targets the pro-inflammatory cytokine TNF-alpha. Its specific binding to TNF-alpha and ability to promote its clearance make it a potential treatment option for various inflammatory diseases. Ongoing research and clinical trials will provide more insight into the efficacy and safety of this antibody, paving the way for its potential use in the clinic.

Alexa Fluor® 647 Anti-TNF-alpha antibody [EPR21753-109], Abcam, AB300093

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Alexa Fluor® is a registered trademark of Molecular Probes, Inc, a Thermo Fisher Scientific Company. The Alexa Fluor® dye included in this product is provided under an intellectual property license from Life Technologies Corporation. As this product contains the Alexa Fluor® dye, the purchase of this product conveys to the buyer the non-transferable right to use the purchased product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). As this product contains the Alexa Fluor® dye the sale of this product is expressly conditioned on the buyer not using the product or its components, or any materials made using the product or its components, in any activity to generate revenue, which may include, but is not limited to use of the product or its components: in manufacturing; (ii) to provide a service, information, or data in return for payment (iii) for therapeutic, diagnostic or prophylactic purposes; or (iv) for resale, regardless of whether they are sold for use in research. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or [email protected].

Alexa Fluor® 647 Anti-TNF alpha antibody [EPR22598-212], Abcam, AB318238

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Alexa Fluor® is a registered trademark of Molecular Probes, Inc, a Thermo Fisher Scientific Company. The Alexa Fluor® dye included in this product is provided under an intellectual property license from Life Technologies Corporation. As this product contains the Alexa Fluor® dye, the purchase of this product conveys to the buyer the non-transferable right to use the purchased product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). As this product contains the Alexa Fluor® dye the sale of this product is expressly conditioned on the buyer not using the product or its components, or any materials made using the product or its components, in any activity to generate revenue, which may include, but is not limited to use of the product or its components: in manufacturing; (ii) to provide a service, information, or data in return for payment (iii) for therapeutic, diagnostic or prophylactic purposes; or (iv) for resale, regardless of whether they are sold for use in research. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or [email protected].

Alexa Fluor® 488 Anti-TNF alpha antibody [EPR21753-109], Abcam, AB283321

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Alexa Fluor® is a registered trademark of Molecular Probes, Inc, a Thermo Fisher Scientific Company. The Alexa Fluor® dye included in this product is provided under an intellectual property license from Life Technologies Corporation. As this product contains the Alexa Fluor® dye, the purchase of this product conveys to the buyer the non-transferable right to use the purchased product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). As this product contains the Alexa Fluor® dye the sale of this product is expressly conditioned on the buyer not using the product or its components, or any materials made using the product or its components, in any activity to generate revenue, which may include, but is not limited to use of the product or its components: in manufacturing; (ii) to provide a service, information, or data in return for payment (iii) for therapeutic, diagnostic or prophylactic purposes; or (iv) for resale, regardless of whether they are sold for use in research. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, 5781 Van Allen Way, Carlsbad, CA 92008 USA or [email protected].

TNF Alpha Induced Protein 8 Recombinant Antbody Kit (KD-Validated), Bioss, bsm-90498r-50uL-ab-25ug-cell-lysate-25ug-wt-cell

anti-human TNF-alpha monoclonal antibody Anti-Human 500 µg, Reliatech, 101-M17

Produced in BALB/c mice using highly pure (>98%) recombinant human TNF-alpha as the immunizing antigen. This IgG1K antibody was purified from cell culture by Protein G affinity chromatography.

APC anti-mouserat TNF-alpha Antibody anti-TNF - TN3-1912, BioLegend, 506107

ELISA or ELISPOT Capture1:The Ultra-LEAF™ Purified TN3-19.12 antibody is useful as the capture antibody in a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated Poly5160 antibody (Cat. No. 516003) as the detecting antibody for detecting mouse/rat TNF-a. The Ultra-LEAF™ purified antibody is suggested for ELISPOT capture.Clone TN3-19.12 has been shown to neutralize murine TNF-a and cross reacts wtih mouse TFN-ß1. The Ultra-LEAF™ Purified antibody (Endotoxin < 0.01 EU/µg, Aside free, 0.2 µm filtered) is recommended for neutralization (Cat. Nos. 506109 - 506114).

APC anti-mouserat TNF-alpha Antibody anti-TNF - TN3-1912, BioLegend, 506108

ELISA or ELISPOT Capture1:The Ultra-LEAF™ Purified TN3-19.12 antibody is useful as the capture antibody in a sandwich ELISA or ELISPOT assay, when used in conjunction with biotinylated Poly5160 antibody (Cat. No. 516003) as the detecting antibody for detecting mouse/rat TNF-a. The Ultra-LEAF™ purified antibody is suggested for ELISPOT capture.Clone TN3-19.12 has been shown to neutralize murine TNF-a and cross reacts wtih mouse TFN-ß1. The Ultra-LEAF™ Purified antibody (Endotoxin < 0.01 EU/µg, Aside free, 0.2 µm filtered) is recommended for neutralization (Cat. Nos. 506109 - 506114).